A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-Finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects with Early Alzheimer's Disease (BAN2401-G000-201)

⋮

0

← $

..going to article 7

X Mark channel Not-Safe-For-Work? cancel confirm NSFW Votes: (0 votes)

X Are you the publisher? Claim or contact us about this channel.

X No ratings yet.

X Search